In cellular biology, the role of reactive oxygen species (ROS) has evolved from being perceived merely as harmful metabolic ...

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its ...

New York, USA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Allogeneic Hematopoietic Stem Cell Transplant Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight DelveInsight’s Allogeneic ...

Researchers have reproduced the developmental process of blood stem cells in vitro, enhancing our understanding of how these ...

According to Precedence Research, the global stem cell therapy market size was valued at USD 14.15 billion in 2023 and is ...

Sergio A. Giralt, MD, discusses what the most commonly used conditioning regimens for patients with myelodysplastic syndrome undergoing transplants are.

Researchers at Kumamoto University have achieved a notable advancement in stem cell biology by reproducing the developmental ...

Researchers at Kumamoto University have achieved a groundbreaking advancement in stem cell biology by reproducing the developmental process of ...

Researchers at Kumamoto University have achieved a groundbreaking advancement in stem cell biology by reproducing the ...

Leukemia stem cells (LSCs) pose a significant challenge in treating acute myeloid leukemia (AML) due to their resistance to ...

Researchers from the School of Veterinary Medicine and Perelman School of Medicine have found that YY1 knockout pro-B cells can generate T lineage cells helping B cells produce antibodies.

A collaborative effort between investigators at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and Massachusetts General Hospital (MGH), a founding ...